NCT01834170View on ClinicalTrials.gov

EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Pancreatic Adenocarcinoma
Interventions
DRUG

Gemcitabine

"Two intratumoral injections of gemcitabine under endoscopic ultrasound (EUS)-guidance at month 0 and month 3.~The patients will receive systemic chemotherapy with or without radiotherapy at the discretion of oncologist"

Trial Locations (1)

Unknown

Digestive Disease Research Center, Shariati ospital, Tehran

All Listed Sponsors
lead

University of Tehran

OTHER

NCT01834170 - EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer | Biotech Hunter | Biotech Hunter